SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CVS Health Corp. – ‘DEFA14A’ on 4/1/22

On:  Friday, 4/1/22, at 4:33pm ET   ·   Accession #:  1206774-22-966   ·   File #:  1-01011

Previous ‘DEFA14A’:  ‘DEFA14A’ on 4/2/21   ·   Next:  ‘DEFA14A’ on 9/6/22   ·   Latest:  ‘DEFA14A’ on 4/5/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/01/22  CVS Health Corp.                  DEFA14A                1:166K                                   DG3/FA

Additional Definitive Proxy Soliciting Material   —   Schedule 14A   —   Rule 14a-12

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: DEFA14A     Definitive Additional Proxy Soliciting Materials    HTML     28K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No. )

Filed by the Registrant Filed by a party other than the Registrant      

CHECK THE APPROPRIATE BOX:
  Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
  Definitive Additional Materials
Soliciting Material under §240.14a-12

CVS Health Corporation

(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY):
  No fee required
Fee paid previously with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11


 

      Your Vote Counts!  
      CVS HEALTH CORPORATION  
      2022 Annual Meeting  
      May 11, 2022 at 8:00 AM ET  
      www.virtualshareholdermeeting.com/CVS2022  
      Vote by May 10, 2022 at 11:59 PM ET  
         
         
  CVS HEALTH CORPORATION
C/O EQUINITI SHAREOWNER SERVICES
P.O. BOX 64945
ST. PAUL, MN 55164-0945
     
         
         
         
         
         
  D75526-P67248-Z81881      

 

You invested in CVS HEALTH CORPORATION and it’s time to vote!

You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the annual meeting of stockholders to be held on May 11, 2022.

 

Get informed before you vote

View the Notice of 2022 Annual Meeting of Stockholders and Proxy Statement and 2021 Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 27, 2022. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

 

     
For complete information and to vote, visit www.ProxyVote.com
Control #
     

 

Smartphone users

 

Point your camera here and
vote without entering a
control number

   

We urge you to vote in advance, but you may also vote virtually at the Annual Meeting*

 

May 11, 2022
8:00 AM, ET


 

Virtually at:
www.virtualshareholdermeeting.com/CVS2022

       

 

* Please check the meeting materials for any special requirements for meeting attendance.
  V1.1

Vote at www.ProxyVote.com  

 

THIS IS NOT A VOTABLE BALLOT

 

This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters.

   

 

 

Voting Items Board
Recommends
1. Election of Directors  
  Nominees:  
1a. Fernando Aguirre          For
1b.  C. David Brown II            For
1c. Alecia A. DeCoudreaux  For
1d. Nancy-Ann M. DeParle  For
1e. Roger N. Farah  For
1f. Anne M. Finucane  For
1g. Edward J. Ludwig  For
1h. Karen S. Lynch  For
1i. Jean-Pierre Millon  For
1j. Mary L. Schapiro  For
1k. William C. Weldon  For
2. Ratification of the appointment of our independent registered public accounting firm for 2022.  For
3. Say on Pay, a proposal to approve, on an advisory basis, the Company’s executive compensation.  For
4. Stockholder proposal for reducing our ownership threshold to request a special stockholder meeting.  Against
5. Stockholder proposal regarding our independent Board Chair.  Against
6. Stockholder proposal on civil rights and non-discrimination audit focused on “non-diverse” employees.  Against
7. Stockholder proposal requesting paid sick leave for all employees.  Against
8. Stockholder proposal regarding a report on the public health costs of our food business to diversified portfolios.  Against
NOTE: In their discretion, the proxies may vote on such other business as may properly come before the meeting or any adjournment thereof.  
   
   
Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”.

 

 

  D75527-P67248-Z81881


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘DEFA14A’ Filing    Date    Other Filings
5/11/223,  3/A,  4,  8-K,  DEF 14A,  PX14A6G
5/10/22PX14A6G
4/27/22
Filed on:4/1/224,  DEF 14A
 List all Filings 
Top
Filing Submission 0001206774-22-000966   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 12:39:06.1am ET